Clinical Trials Sponsored by Blackwell Device Consulting

Total 10 results

Blackwell Device Consulting
Emblation Limited

Recruiting

Microwave Treatment of Common and Plantar Warts

Warts

United States
Blackwell Device Consulting
Emblation Limited

Recruiting

Microwave Treatment for Actinic Keratosis

Keratosis, Actinic

United States, Germany
Rex Bionics Plc
Generic Devices Consulting, Inc.

Completed

Safety and Feasibility Evaluation of Robot Assisted Physiotherapy Exercises With REX (RAPPER II)

Spinal Cord Injury

Australia, United Kingdom, New Zealand
Capso Vision, Inc.
Generic Devices Consulting, Inc.

Completed

Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System

Ulcer | Inflammatory Bowel Diseases | Celiac Disease | Crohn Disease | Intestinal Disease

United States
Generic Devices Consulting, Inc.
Biocompatibles UK Ltd

Terminated

Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer (PARAGON)

Unresectable Metastatic Colo-rectal Cancer

United States
Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Completed

A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART

Infertility

Argentina
Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Unknown

Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 )

Rheumatoid Arthritis

Argentina
Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Unknown

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Breast Cancer

Argentina
Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Completed

Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis (GEMENE)

Rheumatoid Arthritis

Argentina
University Hospital Inselspital, Berne
Novartis; University of Bern; Adverse Drug Reactions, Advice and Consulting ADR-AC

Completed

Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients

Chronic Idiopathic Urticaria | Chronic Urticaria | Chronic Spontaneous Urticaria

Switzerland

Clinical Trials Sponsored by Blackwell Device Consulting

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations